Mr and Ms Kimboi, both of whom are HIV-positive, at the MSF Chakpikarong clinic. They’ve come to the clinic for a check-up and to collect their medication. MSF started providing specialised care for HIV and TB in Manipur in 2005 and 2007, respectively.
Issue brief |

In 2020, around 1.5 million people were newly infected with HIV. Global targets endorsed at the World Health Assembly 2022 aim to reduce new HIV infections from 1.5 million to under 370,000 by 2025 and under 335,000 by 2030. In order to meet these targets, it will be essential to expand access to HIV prevention medicines known as pre-exposure prophylaxis (PrEP).

Read more
Photograph by Jan-Joseph Stok

Work you can support right now!

Prepare for the Future

Currently, many low- and middle-income countries (LMICs) are almost entirely dependent on imports and donations of COVID and other vaccines, contributing to vaccine inequity.  

If mRNA vaccine technology from Moderna, BioNTech and Pfizer were shared, manufacturers in low- and middle-income countries could produce vaccines for global pandemic preparedness, as well as diseases of concern such as HIV, TB and malaria.

How you can support

What good is a breakthrough medicine if the people who need it can't afford it?